This is not unexpected, since skeletal muscle cells are a direct target of misfolded protein toxicity in both ALS and SBMA; therefore, the enhanced production of HSPB8 may serve to protect this tissue during disease progression. This evidence concerns the gene HSPB8 and amyotrophic lateral sclerosis.